No Data
No Data
Biodexa Announces Additional Positive Results Of Phase 2 Trial Of ERapa in Treatment Of Precancerous Polyps in the GI Tract - Now 12-Month Data
CARDIFF, UK / ACCESSWIRE / July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a pipeline of innovative products for
Sector Update: Health Care
Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.7%.The iShares Biotechnology ETF (IBB) climbed 2.4%.
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Conagra Brands, Inc. (NYSE:CAG) fell during Thursday's session after the company reported worse-than-expected fourth-quarter sales results and issued FY25 adjusted EPS guidance below
Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why
Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) announced progress on eRapa, its drug to treat Familial Adenomatous Polyposis (FAP), an inherited disorder characterized by cancer of the large intestine (
Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 points on Thursday.The Dow traded up 0.21% to 39,803.00 while the NASDAQ fell 1.81% to 18,310.23. The
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.19% to 1,460.27 on the S&P Europe Select ADR Index.From continental
No Data